Of the 10 tumor samples obtained from ICB-resistant patients, eight (80%) were positive for ROR1, with five samples showing strong positivity and three showing weak positivity, while nonmalignant cells in adjacent normal tissues exhibited minimal ROR1 expression (Fig. 1C–D, Figure S1A). This evidence concerns the gene ROR1 and neoplasm.